Zebing Liu

827 total citations
38 papers, 514 citations indexed

About

Zebing Liu is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Zebing Liu has authored 38 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Zebing Liu's work include Lymphoma Diagnosis and Treatment (7 papers), Genetic factors in colorectal cancer (5 papers) and Viral-associated cancers and disorders (4 papers). Zebing Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Genetic factors in colorectal cancer (5 papers) and Viral-associated cancers and disorders (4 papers). Zebing Liu collaborates with scholars based in China, United States and United Kingdom. Zebing Liu's co-authors include Ping Wei, Xiang Du, Lisha Wang, Rui Bi, Xiuying Xiao, Anqi Li, Weige Wang, Fei Ren, Wenli Cui and Xiaohan Shen and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Zebing Liu

33 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zebing Liu China 13 249 190 134 125 113 38 514
C. Cebotaru Romania 12 275 1.1× 177 0.9× 122 0.9× 89 0.7× 150 1.3× 24 517
Ana Teresa Amaral Spain 13 317 1.3× 206 1.1× 244 1.8× 150 1.2× 69 0.6× 20 633
Sandeep Reddy United States 8 159 0.6× 222 1.2× 93 0.7× 138 1.1× 150 1.3× 18 458
Biao Liu China 17 276 1.1× 176 0.9× 209 1.6× 200 1.6× 61 0.5× 36 602
Evdokia Arkoumani Greece 12 189 0.8× 173 0.9× 122 0.9× 129 1.0× 91 0.8× 21 481
Gian Paolo Spinelli Italy 15 132 0.5× 190 1.0× 158 1.2× 131 1.0× 91 0.8× 50 514
Anastasios Kyriazoglou Greece 13 222 0.9× 191 1.0× 217 1.6× 130 1.0× 59 0.5× 60 610
Artit Jinawath Thailand 12 221 0.9× 133 0.7× 68 0.5× 84 0.7× 64 0.6× 32 451
Heejin Bang South Korea 10 217 0.9× 142 0.7× 95 0.7× 100 0.8× 68 0.6× 21 411
Sumi Yun South Korea 12 190 0.8× 215 1.1× 119 0.9× 150 1.2× 47 0.4× 25 469

Countries citing papers authored by Zebing Liu

Since Specialization
Citations

This map shows the geographic impact of Zebing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebing Liu more than expected).

Fields of papers citing papers by Zebing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zebing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebing Liu. The network helps show where Zebing Liu may publish in the future.

Co-authorship network of co-authors of Zebing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zebing Liu. A scholar is included among the top collaborators of Zebing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zebing Liu. Zebing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zebing, Chen Chen, Haimin Xu, et al.. (2025). Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in gastric adenosquamous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(6). 1347–1355.
2.
Chen, Zhuang, Yi Luo, Qian Jia, et al.. (2025). NIR‐II Fluorescence Imaging‐guided Photothermal Activated Pyroptosis For Precision Therapy Of Glioma. ChemBioChem. 26(4). e202400804–e202400804. 1 indexed citations
4.
Xiao, Fei, Zebing Liu, Yanying Shen, et al.. (2024). Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review. International Journal of Molecular Sciences. 25(13). 7293–7293. 1 indexed citations
5.
Febres‐Aldana, Christopher A., Zebing Liu, Raymond G. Dematteo, et al.. (2024). HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor. Clinical Cancer Research. 30(20). 4701–4713. 6 indexed citations
6.
Elkrief, Arielle, Igor Odintsov, Roger S. Smith, et al.. (2024). Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification. JCO Precision Oncology. 8(8). e2400241–e2400241. 3 indexed citations
8.
Qiu, Shimei, Jun Hu, Ziyi Wang, et al.. (2024). Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder Cancer with Direct Hepatic Invasion. International Journal of Medical Sciences. 21(5). 862–873. 2 indexed citations
9.
Shen, Yanying, Ling Zhao, Anqi Li, et al.. (2023). Rare myxoid pleomorphic liposarcoma: a case report and literature review. Journal of Clinical Pathology. 77(5). 358–362. 2 indexed citations
10.
Liu, Zebing, Xu Yang, Malin Liu, et al.. (2023). Ultra-high temperature microstructural changes of SiC layers in TRISO particles. Ceramics International. 50(1). 2331–2339. 6 indexed citations
11.
Li, Jun, et al.. (2023). LRP5-/6 gene polymorphisms and its association with risk of abnormal bone mass in postmenopausal women. Journal of Orthopaedic Surgery and Research. 18(1). 369–369.
12.
Yang, Xu, Zebing Liu, Rongzheng Liu, et al.. (2022). Experimental study on the scale-up of a multi-ring inclined nozzle spout-fluid bed by electrical capacitance tomography. International Journal of Chemical Reactor Engineering. 20(9). 1003–1015. 1 indexed citations
13.
Weng, Weiwei, Lin Yu, Zhang Li, et al.. (2022). The immune subtypes and landscape of sarcomas. BMC Immunology. 23(1). 46–46. 15 indexed citations
14.
Odintsov, Igor, Zebing Liu, Lukas Delasos, et al.. (2021). The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions. Clinical Cancer Research. 27(11). 3154–3166. 31 indexed citations
15.
Cui, Wenli, Shutao Zheng, Zebing Liu, et al.. (2017). PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro. OncoTargets and Therapy. Volume 10. 2239–2247. 10 indexed citations
16.
Wang, Lisha, Zebing Liu, Kurt W. Fisher, et al.. (2017). Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer. Human Pathology. 71. 20–29. 34 indexed citations
17.
Chen, Weixiang, Jun Ding, Long Jiang, et al.. (2016). DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array. Functional & Integrative Genomics. 17(1). 85–96. 12 indexed citations
18.
Liu, Zebing, Ping Wei, Yu Yang, et al.. (2015). BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs. Clinical Cancer Research. 21(7). 1752–1763. 31 indexed citations
19.
Wang, Lisha, Xiaohan Shen, Zhimin Wang, et al.. (2015). A molecular signature for the prediction of recurrence in colorectal cancer. Molecular Cancer. 14(1). 22–22. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026